Humira Coupons & Prices

Humira (adalimumab) is a brand-name biologic injection with no substitutable generic, so the price you pay depends heavily on your coverage and your pharmacy. A free Humira coupon from Rx.com is a cash-pay discount you can use at a participating pharmacy when you do not have insurance, when Medicare rules leave you paying cash, or when the manufacturer's savings card is declined. Enter your ZIP code above to see today's price near you, and compare it with your insurance copay and with the adalimumab biosimilars your prescriber may be able to switch you to.

What is Humira and how does it work?

Humira is adalimumab, a human IgG1 monoclonal antibody given as a subcutaneous injection (an injection under the skin). It is a tumor necrosis factor (TNF) blocker and a biologic disease-modifying antirheumatic drug (DMARD). TNF is a protein in the body that drives inflammation. By binding TNF and blocking its activity, adalimumab lowers the inflammation behind several immune-driven conditions.

The FDA has approved Humira for moderate to severe rheumatoid arthritis in adults; polyarticular juvenile idiopathic arthritis in children 2 years and older; psoriatic arthritis in adults; ankylosing spondylitis in adults; Crohn's disease in adults and children 6 years and older; ulcerative colitis in adults and children 5 years and older; moderate to severe chronic plaque psoriasis in adults who are candidates for systemic therapy or phototherapy; hidradenitis suppurativa in patients 12 years and older; and non-infectious intermediate, posterior, and panuveitis in patients 2 years and older. Your prescriber decides the dose and schedule for your condition. This page is information only, not medical advice.

Manufacturer savings card vs. the Rx.com cash coupon

AbbVie runs an official savings program for Humira, described on the manufacturer's own website (humira.com). Like most manufacturer copay cards, it is generally limited to people with commercial (private) insurance, and the terms, eligibility rules, and any limits vary and change over time, so read the program's current terms yourself before counting on it. People with Medicare, Medicaid, other government coverage, or no insurance at all are typically not eligible. AbbVie also operates a patient assistance program for people who qualify based on income and insurance status, which is separate from the copay card and worth asking your prescriber's office about.

The Rx.com coupon is different: it is a cash-pay discount, not insurance and not a copay card. It is the option that still works when you are uninsured, when you are on Medicare, or when the pharmacy tells you the manufacturer card was declined. It is free to use and there is no membership. Enter your ZIP code above to see today's cash price at pharmacies near you, then compare that against your insurance copay and pick whichever is lower. Prices vary a lot by pharmacy, so it is worth comparing.

Is there a generic? Biosimilars and other options

There is no generic Humira. Because adalimumab is a biologic, the lower-cost alternatives are biosimilars, not generics. FDA-approved adalimumab biosimilars marketed in the US include Amjevita (adalimumab-atto), Cyltezo (adalimumab-adbm), Hyrimoz (adalimumab-adaz), Hadlima (adalimumab-bwwd), Yuflyma (adalimumab-aaty), Hulio, Idacio, Yusimry, Abrilada, and Simlandi, along with some unbranded adalimumab products. Some of these are designated interchangeable, which in many states can allow a pharmacy substitution, while others require your prescriber to write for that specific product. Prices differ between these products and between pharmacies, so compare rather than assume any one is cheapest.

If adalimumab is not the right fit, prescribers may consider other TNF blockers such as Enbrel, Remicade, Cimzia, or Simponi; biologics with a different target such as Stelara; oral JAK inhibitors such as Rinvoq or Xeljanz; or a conventional DMARD such as methotrexate. These are not equivalent to one another, and the right choice depends on your diagnosis and history. Talk with your prescriber before changing anything.

Safety information you should know

Humira carries an FDA boxed warning for serious infections and malignancy. Serious infections leading to hospitalization or death have occurred, including tuberculosis (often reactivation of latent TB), invasive fungal infections such as histoplasmosis, coccidioidomycosis, and blastomycosis, and other bacterial, viral, and opportunistic infections. You should be tested for latent TB before starting and monitored during treatment, and latent TB should be treated first. Treatment should be stopped if a serious infection or sepsis develops. Risk is higher when adalimumab is combined with other immunosuppressants such as methotrexate or corticosteroids. The malignancy part of the boxed warning covers lymphoma and other cancers, some fatal, reported in children and adolescents on TNF blockers, and postmarketing cases of hepatosplenic T-cell lymphoma, a rare and usually fatal lymphoma seen mostly in adolescent and young adult males with Crohn's disease or ulcerative colitis taking adalimumab along with azathioprine or 6-mercaptopurine.

Other important risks on the label include hepatitis B reactivation in chronic carriers, new or worsening demyelinating disease (such as multiple sclerosis, optic neuritis, or Guillain-Barre syndrome), new or worsening congestive heart failure, low blood counts including rare aplastic anemia, hypersensitivity reactions including anaphylaxis, lupus-like syndrome, and rare severe liver reactions. Live vaccines should not be given during treatment, so bring immunizations up to date beforehand. Humira should not be combined with anakinra, abatacept, or other biologic DMARDs because of added infection risk. The most common side effects are injection-site reactions, upper respiratory infections, sinusitis, headache, and rash. This is a summary, not the full label and not medical advice. Read the medication guide and talk with your prescriber or pharmacist about your own situation.